1-4 of 4
Steven A Schaffert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prediction of Clinical Response to Venetoclax Plus Decitabine in AML Using a 7-Day Ex Vivo Assay

Free
Markus D Lacher, Michelle A Richardson, Steven A Schaffert, Ryosuke Kita, Marianne T Santaguida, Erica K Anderson, Jordan Roselli, Wade Anderson, Arisa Paul, Christine Gu, Kathryn Vanderlaag, Zhihong Zeng, Abhishek Maiti, Courtney D. DiNardo, Marina Konopleva
Journal: Blood
Blood (2021) 138 (Supplement 1): 3464.
https://doi.org/10.1182/blood-2021-148891
Published: 2021
Journal Articles

MDS and MDS/MPN Genomic Subgroups Demonstrate Differential E x Vivo Drug Sensitivity

Free
Michael A Spinner, Steven A Schaffert, Henning Stehr, Marianne T Santaguida, Ryosuke Kita, Alexey Aleshin, James L Zehnder, Peter L. Greenberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 4645.
https://doi.org/10.1182/blood-2021-152103
Published: 2021
Journal Articles

Correlating Clinical and Genomic Features with E x Vivo Drug Sensitivity in Patients with Myelodysplastic Syndromes and Related Myeloid Neoplasms

Free
Michael A Spinner, MD, Steven A Schaffert, PhD, Alexey Aleshin, MD MBA, Marianne T Santaguida, PhD, Hiroomi Tada, MDPhD, Peter L. Greenberg
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140095
Published: 2020
Journal Articles

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Free
Michael A Spinner, Alexey Aleshin, MD MBA, Marianne A Santaguida, PhD, Steven A Schaffert, PhD, Taher Abbasi, MS, MBA, Jeffrey N Sanders, A Scott Patterson, MA, Diane Heiser, PhD, James L Zehnder, Peter L Greenberg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4239.
https://doi.org/10.1182/blood-2019-129473
Published: 2019